ID

22305

Description

Pramipexole Conversion to Ropinirole Controlled Release (CR); ODM derived from: https://clinicaltrials.gov/show/NCT00275275

Lien

https://clinicaltrials.gov/show/NCT00275275

Mots-clés

Versions (1)
  1. 29/05/2017 29/05/2017 -
Téléchargé le

29 mai 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Parkinson Disease NCT00275275

Anglais

Eligibility Parkinson Disease NCT00275275

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of parkinson disease
Description

Parkinson Disease

Type de données

boolean

Alias
UMLS CUI [1]
C0030567
currently taking pramipexole
Description

Pramipexole

Type de données

boolean

Alias
UMLS CUI [1]
C0074710
never have taken requip cr
Description

Requip CR Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0593342
UMLS CUI [1,2]
C0868939
UMLS CUI [1,3]
C0332197
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
can not have significant adverse effects to standard requip
Description

Adverse effects Requip

Type de données

boolean

Alias
UMLS CUI [1,1]
C0879626
UMLS CUI [1,2]
C0593342
can not have atypical pd due to drugs, metabolic disorders, encephalitis or degenerative diseases
Description

Atypical Parkinson Disease Due to Pharmaceutical Preparations | Atypical Parkinson Disease Due to Metabolic Diseases | Atypical Parkinson Disease Due to Encephalitis | Atypical Parkinson Disease Due to Degenerative disorder

Type de données

boolean

Alias
UMLS CUI [1,1]
C1868596
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C0013227
UMLS CUI [2,1]
C1868596
UMLS CUI [2,2]
C0678226
UMLS CUI [2,3]
C0025517
UMLS CUI [3,1]
C1868596
UMLS CUI [3,2]
C0678226
UMLS CUI [3,3]
C0014038
UMLS CUI [4,1]
C1868596
UMLS CUI [4,2]
C0678226
UMLS CUI [4,3]
C1285162
can not have unstable medical conditions
Description

Medical condition Unstable

Type de données

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0443343
can not be taking concurrent monoamine oxidase inhibitors except for selegiline (10mg per day or less)
Description

Monoamine Oxidase Inhibitors | Selegiline U/day

Type de données

boolean

Alias
UMLS CUI [1]
C0026457
UMLS CUI [2,1]
C0036579
UMLS CUI [2,2]
C0456683
female patients of childbearing potential must be using an effective method of contraception.
Description

Childbearing Potential Contraceptive methods

Type de données

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
can not be pregnant or lactating.
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
this may not be a complete list; there may be additional criteria which may apply.
Description

Clinical Trial Eligibility Criteria Additional

Type de données

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C1524062
Retour au début de la page

Similar models

Eligibility Parkinson Disease NCT00275275

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Parkinson Disease
Item
diagnosis of parkinson disease
boolean
C0030567 (UMLS CUI [1])
Pramipexole
Item
currently taking pramipexole
boolean
C0074710 (UMLS CUI [1])
Requip CR Absent
Item
never have taken requip cr
boolean
C0593342 (UMLS CUI [1,1])
C0868939 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Adverse effects Requip
Item
can not have significant adverse effects to standard requip
boolean
C0879626 (UMLS CUI [1,1])
C0593342 (UMLS CUI [1,2])
Atypical Parkinson Disease Due to Pharmaceutical Preparations | Atypical Parkinson Disease Due to Metabolic Diseases | Atypical Parkinson Disease Due to Encephalitis | Atypical Parkinson Disease Due to Degenerative disorder
Item
can not have atypical pd due to drugs, metabolic disorders, encephalitis or degenerative diseases
boolean
C1868596 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C1868596 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0025517 (UMLS CUI [2,3])
C1868596 (UMLS CUI [3,1])
C0678226 (UMLS CUI [3,2])
C0014038 (UMLS CUI [3,3])
C1868596 (UMLS CUI [4,1])
C0678226 (UMLS CUI [4,2])
C1285162 (UMLS CUI [4,3])
Medical condition Unstable
Item
can not have unstable medical conditions
boolean
C3843040 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
Monoamine Oxidase Inhibitors | Selegiline U/day
Item
can not be taking concurrent monoamine oxidase inhibitors except for selegiline (10mg per day or less)
boolean
C0026457 (UMLS CUI [1])
C0036579 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
Childbearing Potential Contraceptive methods
Item
female patients of childbearing potential must be using an effective method of contraception.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
can not be pregnant or lactating.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Clinical Trial Eligibility Criteria Additional
Item
this may not be a complete list; there may be additional criteria which may apply.
boolean
C1516637 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial